The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.

India Pharma Producing COVID19 Drugs For Masses 
 Known for its expertise in manufacturing and supplyingquality generic drugs, Indian pharma sector is currentlyusing the generic tool as a critical arsenal in the fight againstCOVID–19. At present, there are around 25 different drugsbrands available in the Indian market to treat the COVID-19 patients, with many more in the pipeline.  
--

Discover the best professional documents and content resources in AnyFlip Document Base.
Search
Published by MMA Media, 2020-09-04 09:37:12

BioSpectrum Asia Sep 2020 ( North America Edition )

India Pharma Producing COVID19 Drugs For Masses 
 Known for its expertise in manufacturing and supplyingquality generic drugs, Indian pharma sector is currentlyusing the generic tool as a critical arsenal in the fight againstCOVID–19. At present, there are around 25 different drugsbrands available in the Indian market to treat the COVID-19 patients, with many more in the pipeline.  
--

Keywords: Pharma,Biotech,HealthScience

Cubis® II: Your Balance,
Your Way

The New Generation of Modular Premium Balances
For scientists in R&D and analytical laboratories needing the most
reliable lab weighing results, the Cubis® II from Sartorius is a completely
configurable, high performance portfolio of balance hardware and software
that will align with your unique demands and compliance requirements to
maximize operational efficiency and experimental outcomes.

sartorius.com/cubis-ii


Click to View FlipBook Version